BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7166918)

  • 1. [Immunological detection of an antigen associated with human bladder carcinoma cell lines].
    Tsukahara K
    Nihon Hinyokika Gakkai Zasshi; 1982 Oct; 73(10):1249-58. PubMed ID: 7166918
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of antigenic differences and similarities between human transitional cell carcinoma cell lines using rabbit antisera.
    Bloom ET; Brown DE
    Urol Res; 1980; 8(1):5-13. PubMed ID: 6154368
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunological characterization of cell lines establishing from malignant and normal human urothelium.
    Vilien M; Wolf H; Rasmussen F
    Eur J Cancer (1965); 1981 Mar; 17(3):321-7. PubMed ID: 7262169
    [No Abstract]   [Full Text] [Related]  

  • 4. The detection of transitional cell bladder cancer antigen on established cell lines.
    Boxer RJ; Sofen H; Saxon A
    Invest Urol; 1981 Sep; 19(2):70-4. PubMed ID: 7024183
    [No Abstract]   [Full Text] [Related]  

  • 5. Transitional cell carcinoma of the bladder. Differences between primary tumour and following relapses.
    Pizza G; Viza D; Fini M; Cuzzocrea D; Menniti D; Corrado F
    Eur Urol; 1980; 6(1):45-7. PubMed ID: 7353578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of antigens on transitional cell carcinoma with a xenogeneic antiserum.
    Bloom ET
    Natl Cancer Inst Monogr; 1978 Dec; (49):57-8. PubMed ID: 86168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen(s) on human transitional cell carcinoma detected by a xenogeneic antiserum.
    Bloom ET
    Urol Res; 1977; 5(3):141-8. PubMed ID: 919114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of surface ABO(H) isoantigens in transitional cell carcinoma of the bladder. Clinicopathological study. (Part 1)].
    Gelabert Mas A; Corominas J; Arango O
    Actas Urol Esp; 1988; 12(3):248-53. PubMed ID: 3177059
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prognostic evaluation of patients with cancer of the bladder by detection of ABH surface antigens].
    Srougi M; Alves VA; Gayotto LC; Raia S; Arap S
    AMB Rev Assoc Med Bras; 1987; 33(3-4):67-70. PubMed ID: 3501142
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.
    Bubeník J
    Int Urol Nephrol; 1975; 7(4):297-302. PubMed ID: 1107249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma membrane-associated antigens on tumor cells derived from transitional-cell carcinoma of the human urinary bladder. II. Identification at the molecular level of plasma membrane-associated antigens.
    Schneider MU; Paulie S; Troye M; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):193-202. PubMed ID: 7203713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine hybridoma antibodies against human transitional carcinoma-associated antigens.
    Messing EM; Bubbers JE; Whitmore KE; deKernion JB; Nestor MS; Fahey JL
    J Urol; 1984 Jul; 132(1):167-72. PubMed ID: 6202893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of Leu-M1 antigens in carcinoma of the urinary bladder.
    Hoshi S; Orikasa S; Numata I; Nose M
    J Urol; 1986 May; 135(5):1075-7. PubMed ID: 3083124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The study of mouse monoclonal antibody to human transitional cell carcinoma of the bladder].
    Takahashi S; Takahashi N; Takahashi K; Koizumi Y; Kawaguchi T; Togashi S; Suzuki T; Funyu T
    Nihon Hinyokika Gakkai Zasshi; 1987 May; 78(5):791-801. PubMed ID: 3694976
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder.
    Huland E; Huland H; Meier T; Baricordi O; Fradet Y; Grossman HB; Hodges GM; Messing EM; Schmitz-Draeger BJ
    J Urol; 1991 Dec; 146(6):1631-6. PubMed ID: 1719252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-associated antigens on tumor cells from transitional-cell carcinoma of the human urinary bladder. I. Immunological characterization by xenogeneic antisera.
    Schneider MU; Troye M; Paulie S; Perlmann P
    Int J Cancer; 1980 Aug; 26(2):185-92. PubMed ID: 7203712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production and characterization of monoclonal antibodies to the established human bladder cancer cell lines.
    Sasaki M
    Keio J Med; 1984 Apr; 33(1):39-56. PubMed ID: 6384610
    [No Abstract]   [Full Text] [Related]  

  • 19. Potential value of antisera to epithelial membrane antigen in detecting early invasion in transitional cell carcinoma.
    Pocock RD; Ibrahim SK; Sloane JP; Ponder BA; Shearer RJ
    Br J Urol; 1983 Dec; 55(6):670-5. PubMed ID: 6652437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lectins as probes for identification of tumor-associated antigens on urothelial and colonic carcinoma cell lines.
    Paulie S; Hansson Y; Lundblad ML; Perlmann P
    Int J Cancer; 1983 Mar; 31(3):297-303. PubMed ID: 6826254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.